Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Alessandra N L Prezotti, Paula Ribeiro Villaça, Debora M C Rocha, Maria P S V Orletti, Christiane Lourenço, Gabriela G Yamaguti Hayakawa, Margareth C Ozelo

Blood (2022) 140 (Supplement 1): 57–58.

https://doi.org/10.1182/blood-2022-171028

Published: 2022

Journal Articles

First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results

Christoph Königs, Margareth C. Ozelo, Amy Dunn, Roshni Kulkarni, Beatrice Nolan, Simon A. Brown, Michele Schiavulli, Sriya Gunawardena, Sutirtha Mukhopadhyay, Deepthi Jayawardene, Bent Winding, Manuel Carcao

Blood (2022) 139 (26): 3699–3707.

https://doi.org/10.1182/blood.2021013563

Published: 2022

Includes: Supplemental data

Journal Articles

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Blood (2021) 138 (Supplement 1): 3972.

https://doi.org/10.1182/blood-2021-144508

Published: 2021

Journal Articles

Acquired Hemophilia a Relapse Is Related to Th2 Response, and Increased Expression of B-Cell Activating Factor (BAFF)

Jessica O Frade-Guanaes, Ana P Racanelli, Lucia H Siqueira, Carolina Costa-Lima, Samuel S Medina, Nivia M Foschi, Marina P Colella, Silmara A L Montalvão, Gabriela G Yamaguti-Hayakawa, Margareth C Ozelo

Blood (2021) 138 (Supplement 1): 497.

https://doi.org/10.1182/blood-2021-152589

Published: 2021

Journal Articles

Effectiveness and Safety Outcomes in Patients with Hemophilia a Receiving Antihemophilic Factor (Recombinant) for at Least 5 Years in a Real-World Setting: 6-Year Interim Analysis of the Ahead International and German Studies

Dimitrios A. Tsakiris, MD, Johannes Oldenburg, Robert Klamroth, Benoît Guillet, Kate Khair, Angela Huth-Kühne, MD, Karin Kurnik, Stephan Regensburger, Jaco Botha, Alejandro Fernandez, Leilei Tang, Margareth C. Ozelo

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139873

Published: 2020

Journal Articles

The Pro-Adhesive and Reduced Angiogenic Properties of Endothelial Colony Forming Cells (ECFC) from JAK2 V617F MPN Patients Are Not Related to the Expression of the JAK2 mutation in These Cells: A Potential Role of ADAM17

Bruno Kosa Lino Duarte, Stephanie Ospina-Prieto, PhD, Lucia Helena Siqueira, Jessica O F Guanaes, MSc, Fernando Ferreira Costa, MD PhD, Margareth C Ozelo, MD PhD

Blood (2019) 134 (Supplement_1): 3618.

https://doi.org/10.1182/blood-2019-131488

Published: 2019

Journal Articles

Proliferative Sickle Cell Retinopathy in SS and SC Hemoglobinopathies: Identification of New Candidate Genes

Sueli Matilde da Silva Costa, MD PhD, Mirta Tomie Ito, Bruno Batista Souza, PhD, Pedro Rodrigues Souza Cruz, PhD, Letícia de Carvalho Bapista, MD, Vinicius Mandolesi Rios, Marina Gonçalves Monteiro Viturino, Stephanie Ospina Pietro, PhD, Margareth C Ozelo, MD PhD, Fernando F. Costa, MD, PhD, Monica Barbosa Melo, MD PhD

Blood (2018) 132 (Supplement 1): 2368.

https://doi.org/10.1182/blood-2018-99-116312

Published: 2018

Journal Articles

Endothelial Colony-Forming Cells (ECFC) As an Autologous Model for Studying Endothelial Pathophysiology in Sickle Cell Anemia and Myeloproliferative Neoplasms

Stephanie Ospina-Prieto, PhD, Bruno K L Duarte, Jessica O F Guanaes, MSc, Fernando F. Costa, MD, PhD, Margareth C Ozelo, MD PhD

Blood (2018) 132 (Supplement 1): 74.

https://doi.org/10.1182/blood-2018-99-117218

Published: 2018

Journal Articles

Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform

Pierre Chelle, PhD, Cindy Yeung, MSc, Santiago Bonanad Boix, MD, Juan Cristobal Morales, MD, Margareth C Ozelo, MD PhD, Juan E. Megias Vericat, PharmD, Alfonso Iorio, MD PhD, Jeffrey Spears, PharmD, Roser Mir, PhD, Andrea N Edginton, PhD

Blood (2018) 132 (Supplement 1): 1191.

https://doi.org/10.1182/blood-2018-99-115308

Published: 2018

Journal Articles

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Bruno Kosa Lino Duarte, MD, Marcos Paulo Colella, MD MSc, Fernando Vieira Pericole Souza, MD PhD, Gabriela G Yamaguti-Hayakawa, MD, Jose Francisco Comenalli Marques, Jr., MD PhD, Afonso Celso Vigorito, MD PhD, Erich Vinicius De Paula, MD PhD, Margareth C Ozelo, MD PhD

Blood (2018) 132 (Supplement 1): 4762.

https://doi.org/10.1182/blood-2018-99-119884

Published: 2018

Journal Articles

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Alessandra N L Prezotti, MD MSc, Monica H Cerqueira, MD PhD, Marilia Renni, MD MSc, Clarissa Ferreira, MD, Ieda S. Pinto, MD, Maria do Rosário Roberti, MD PhD, Rosangela Ribeiro, MD, Paula Ribeiro Villaça, MD PhD, Maria P S V Orletti, Carolina Costa-Lima, MD MSc, Gabriela G Yamaguti-Hayakawa, MD, Samuel S Medina, MD MSc, Margareth C Ozelo, MD PhD

Blood (2018) 132 (Supplement 1): 1211.

https://doi.org/10.1182/blood-2018-99-119754

Published: 2018

Journal Articles

Somatic Mutations Associated with Myeloid Transformation of RUNX1 -Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing

Bruno K L Duarte, Samuel S Medina, MD, Gabriela G Yamaguti Hayakawa, MD, Fernando Ferreira Costa, MD PhD, Michael J. Rauh, MD PhD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 2482.

https://doi.org/10.1182/blood.V130.Suppl_1.2482.2482

Published: 2017

Journal Articles

Clinical Outcomes of 14-Day Prophylaxis with rFIXFc: Longitudinal Analysis of the B-LONG and B-YOND Study

Amy D. Shapiro, MD, Margareth C Ozelo, MD PhD, K John Pasi, Jingyuan Feng, Bent Winding, Chris Barnowski, Roshni Kulkarni

Blood (2017) 130 (Supplement 1): 3667.

https://doi.org/10.1182/blood.V130.Suppl_1.3667.3667

Published: 2017

Journal Articles

Transcriptome Analysis of Endothelial Colony-Forming Cells Isolated from Patients with HbSC Hemoglobinopathy and Proliferative Retinopathy

Sueli Matilde da Silva Costa, PhD, Mirta Ito, Bruno Souza, Marina Gonçalves Monteiro Viturino, Stephanie Ospina Pietro, Roberta Casagrande, Margareth C Ozelo, MD PhD, Kleber Yotsumoto Fertrin, MD PhD, Fernando Ferreira Costa, MD PhD, Monica Barbosa de Melo, PhD

Blood (2017) 130 (Supplement 1): 4769.

https://doi.org/10.1182/blood.V130.Suppl_1.4769.4769

Published: 2017

Journal Articles

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Bruno K L Duarte, Gabriela G Yamaguti Hayakawa, MD, Francisco A Ferreira, MD, Katia B B Pagnano, MD PhD, Erich Vinicius De Paula, MD PhD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 4651.

https://doi.org/10.1182/blood.V130.Suppl_1.4651.4651

Published: 2017

Journal Articles

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Alessandra N L Prezotti, MD, Clarissa Ferreira, MD, Luciana Oliveira, MD PhD, Claudia Lorenzato, MD PhD, Maria P S V Orletti, Maria do Rosario Roberti, MD PhD, Rosangela Ribeiro, MD, Paula Ribeiro Villaca, MD PhD, Silmara Aparecida De Lima Montalvão, Samuel S Medina, MD, Gabriela G Yamaguti Hayakawa, MD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 2357.

https://doi.org/10.1182/blood.V130.Suppl_1.2357.2357

Published: 2017

Journal Articles

Clinical Outcomes in Adults/Adolescents with Hemophilia B Treated Long Term with Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-Yond Extension Study

Tadashi Matsushita, Johnny Mahlangu, Amy D Shapiro, K John Pasi, Margaret V. Ragni, MD, Margareth C Ozelo, Johannes Oldenburg, Prof, Ross I Baker, Huixing Yuan, Alejandra Ramirez-Santiago, Francesca Ferrante, Stefan Lethagen

Blood (2016) 128 (22): 1416.

https://doi.org/10.1182/blood.V128.22.1416.1416

Published: 2016

Journal Articles

Safety and Efficacy of Turoctocog Alfa in Prevention and on-Demand Treatment of Bleeding Episodes in Patients with Hemophilia A

Dragana Janic, MD PhD, Irina Matytsina, MD, Mudi Misgav, Johannes Oldenburg, Prof, Margareth C Ozelo, Michael Recht, MD PhD, Lars Korsholm, Aleksandar Savic, Elena Santagostino, MD PhD

Blood (2016) 128 (22): 3790.

https://doi.org/10.1182/blood.V128.22.3790.3790

Published: 2016

Journal Articles

Differential Diagnosis of Hereditary and Acquired Thrombocytopenia By the Immature Platelet Fraction and Thrombopoietin Levels

Fabio Luiz Bandeira Ferreira, Marina Pereira Colella, MD PhD, Samuel de Souza Medina, MD, Maiara Marx Luz Fiusa, Loredana Nilkenes Gomes da Costa, Carolina Costa-Lima, MD, Fernanda Andrade Orsi, MDPhD, Joyce Maria Annichino-Bizzacchi, MD PhD, Kleber Yotsumoto Fertrin, MD PhD, Maria de Fatima Pereira Gilberti, MD, Margareth C Ozelo, Erich Vinicius De Paula, MD PhD

Blood (2015) 126 (23): 1049.

https://doi.org/10.1182/blood.V126.23.1049.1049

Published: 2015

Journal Articles

Impact of Two Immobilized GPIbα Assays in the Diagnosis of Von Willebrand Disease

Silmara Lima Montalvão, MSc clinical MDcine, Sandra Martins Silva Soares, Biologist, Marina P Colella, MD, Joyce M Annichino-Bizzacchi, MD PhD, Samuel de Souza Medina, MD, Margareth C Ozelo, MD, PhD

Blood (2014) 124 (21): 1524.

https://doi.org/10.1182/blood.V124.21.1524.1524

Published: 2014

NARROW

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results

Relationship between Endogenous, Transgene FVIII Expression and Bleeding Events Following Valoctocogene Roxaparvovec Gene Transfer for Severe Hemophilia A: A Post-Hoc Analysis of the GENEr8-1 Phase 3 Trial

Acquired Hemophilia a Relapse Is Related to Th2 Response, and Increased Expression of B-Cell Activating Factor (BAFF)

Effectiveness and Safety Outcomes in Patients with Hemophilia a Receiving Antihemophilic Factor (Recombinant) for at Least 5 Years in a Real-World Setting: 6-Year Interim Analysis of the Ahead International and German Studies

The Pro-Adhesive and Reduced Angiogenic Properties of Endothelial Colony Forming Cells (ECFC) from JAK2 V617F MPN Patients Are Not Related to the Expression of the JAK2 mutation in These Cells: A Potential Role of ADAM17

Proliferative Sickle Cell Retinopathy in SS and SC Hemoglobinopathies: Identification of New Candidate Genes

Endothelial Colony-Forming Cells (ECFC) As an Autologous Model for Studying Endothelial Pathophysiology in Sickle Cell Anemia and Myeloproliferative Neoplasms

Creating a Population Model for PK-Tailored Dosing Using Real-World Data from the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Platform

Vinorelbine-Based Hematopoietic Stem-Cell Mobilization: A More Effective, Low-Cost Alternative to Conventional Chemotherapy

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Somatic Mutations Associated with Myeloid Transformation of RUNX1 -Mutated Familial Platelet Disorders with Propensity to Myeloid Malignancies Using Targeted Next-Generation Sequencing

Clinical Outcomes of 14-Day Prophylaxis with rFIXFc: Longitudinal Analysis of the B-LONG and B-YOND Study

Transcriptome Analysis of Endothelial Colony-Forming Cells Isolated from Patients with HbSC Hemoglobinopathy and Proliferative Retinopathy

A Simple Bundle to Control an Outbreak of Carbapenem-Resistant Enterobacteriacae in an Onco-Hematological Inpatient Unit: Report from a Single Center

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Clinical Outcomes in Adults/Adolescents with Hemophilia B Treated Long Term with Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis: Interim Results of the B-Yond Extension Study

Safety and Efficacy of Turoctocog Alfa in Prevention and on-Demand Treatment of Bleeding Episodes in Patients with Hemophilia A

Differential Diagnosis of Hereditary and Acquired Thrombocytopenia By the Immature Platelet Fraction and Thrombopoietin Levels

Impact of Two Immobilized GPIbα Assays in the Diagnosis of Von Willebrand Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only